Detalhe da pesquisa
1.
A pilot study: estradiol/progesterone effect on cervico-vaginal cytokines in premenopause and postmenopause.
Climacteric
; 23(3): 306-310, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107942
2.
Uterine bleeding with hormone therapies in menopausal women: a systematic review.
Climacteric
; 23(6): 550-558, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32893694
3.
TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.
Climacteric
; 22(4): 412-418, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862193
4.
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.
Climacteric
; 20(5): 402-413, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28805475
5.
Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner.
Climacteric
; 18(6): 817-25, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26517756
6.
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy.
Climacteric
; 18(4): 590-607, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25511551
7.
Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
Climacteric
; 16(1): 17-27, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22646219
8.
Estrogen and progestogen effect on venous thromboembolism in menopausal women.
Climacteric
; 15(3): 235-40, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22612609
9.
Menopausal hot flushes and night sweats: where are we now?
Climacteric
; 14(5): 515-28, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21848495
10.
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia.
Climacteric
; 14(2): 282-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21244215
11.
Premature menopause increases cardiovascular risk.
Climacteric
; 12 Suppl 1: 26-31, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19811237
12.
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
Climacteric
; 16(3): 316-37, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23672656
13.
Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
Contraception
; 97(5): 422-427, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409834
14.
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.
Climacteric
; 14(3): 302-20, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21563996
15.
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.
Contraception
; 93(1): 58-64, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26408374
16.
The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women.
Menopause
; 8(4): 245-51, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11449081
17.
A comparative study of transvaginal uterine ultrasound and endometrial biopsy for evaluating the endometrium of postmenopausal women taking hormone replacement therapy.
Menopause
; 6(3): 201-8, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10486789
18.
Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding.
Obstet Gynecol
; 96(6): 899-905, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11084175
19.
Ovarian response to exogenous gonadotropins in women with elevated serum prolactin.
Obstet Gynecol
; 48(2): 155-7, 1976 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-940646
20.
Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Obstet Gynecol
; 83(5 Pt 1): 686-92, 1994 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-8164926